WGS
GeneDx Holdings Corp

4,442
Mkt Cap
$3.7B
Volume
0.00
52W High
$136.00
52W Low
$55.17
PE Ratio
6,891.44
WGS Fundamentals
Price
$129.00
Prev Close
$125.07
Open
$127.43
50D MA
$123.16
Beta
1.67
Avg. Volume
477,021.33
EPS (Annual)
-$1.94
P/B
13.35
Rev/Employee
$305,450.00
Loading...
Loading...
News
all
press releases
Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of GeneDx Holdings Corp. (NASDAQ: WGS) breached their fiduciary duties to shareholders. If you...
Business Wire·1d ago
News Placeholder
More News
News Placeholder
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced data and presentations at the International Consortium on Newborn Sequencing (ICoNS...
Business Wire·3d ago
News Placeholder
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot...
PR Newswire·10d ago
News Placeholder
GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Dr. Mimi Lee, MD, PhD, as Chief Precision Medicine Officer. Dr. Lee will spearhead...
Business Wire·11d ago
News Placeholder
InnovAge (INNV) Surges 8.6%: Is This an Indication of Further Gains?
InnovAge (INNV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks·11d ago
News Placeholder
GeneDx to Partner with Floridas Sunshine Genetics Network, Launching Nations First State-Backed Genomic Newborn Screening Program
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Florida State University has selected GeneDx as one of its partners for the recently...
Business Wire·12d ago
News Placeholder
GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the Autism Partnership Program to expand access to its industry leading exome and...
Business Wire·16d ago
News Placeholder
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2025
GeneDx, Twist Bioscience and Wave Life Sciences are emerging as key players in the fast-growing genomics and synthetic biology space.
Zacks·1mo ago
News Placeholder
Here's Why Ensign Group Shares Are Attracting Investors Now
ENSG stock is surging on revenue growth, acquisitions and raised 2025 earnings and sales guidance.
Zacks·1mo ago
News Placeholder
Here's Why Pediatrix Medical Shares Are Attracting Investors Now
MD shares surge on strong earnings, rising revenues, cost cuts and a new $250M buyback plan.
Zacks·1mo ago

Latest WGS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.